Correlation Between Eupraxia Pharmaceuticals and AptarGroup

Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and AptarGroup at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and AptarGroup into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eupraxia Pharmaceuticals Common and AptarGroup, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and AptarGroup and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of AptarGroup. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and AptarGroup.

Diversification Opportunities for Eupraxia Pharmaceuticals and AptarGroup

0.48

Correlation Coefficient

Eupraxia Pharmaceuticals  AptarGroup

Very weak diversification

The 3 months correlation between Eupraxia and AptarGroup is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals Commo and AptarGroup in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AptarGroup and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals Common are associated (or correlated) with AptarGroup. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AptarGroup has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and AptarGroup go up and down completely randomly.

Pair Corralation between Eupraxia Pharmaceuticals and AptarGroup

Given the investment horizon of 90 days Eupraxia Pharmaceuticals Common is expected to generate 5.58 times more return on investment than AptarGroup. However, Eupraxia Pharmaceuticals is 5.58 times more volatile than AptarGroup. It trades about 0.1 of its potential returns per unit of risk. AptarGroup is currently generating about -0.12 per unit of risk. If you would invest  255.00  in Eupraxia Pharmaceuticals Common on September 26, 2024 and sell it today you would earn a total of  51.00  from holding Eupraxia Pharmaceuticals Common or generate 20.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Eupraxia Pharmaceuticals Commo  vs.  AptarGroup

Eupraxia Pharmaceuticals

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Eupraxia Pharmaceuticals Common are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Eupraxia Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

AptarGroup

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in AptarGroup are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, AptarGroup is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Eupraxia Pharmaceuticals and AptarGroup

The main advantage of trading using opposite Eupraxia Pharmaceuticals and AptarGroup positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, AptarGroup can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptarGroup will offset losses from the drop in AptarGroup's long position.

The idea behind Eupraxia Pharmaceuticals Common and AptarGroup pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.